SEC Filings - Marker Therapeutics, Inc.

Filing date	Form	Description	View
Jun 8, 2023	4	Statement of changes in beneficial ownership of securities	0001209191-23-035617.pdf 0001209191-23-035617.rtf 0001209191-23-035617.xls View HTML
May 31, 2023	8-K	Report of unscheduled material events or corporate event	0001104659-23-066311.pdf 0001104659-23-066311.rtf 0001104659-23-066311.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 15, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001410578-23-001217.pdf 0001410578-23-001217.rtf 0001410578-23-001217.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 11, 2023	4	Statement of changes in beneficial ownership of securities	0001209191-23-028846.pdf 0001209191-23-028846.rtf 0001209191-23-028846.xls View HTML
May 8, 2023	8-K	Report of unscheduled material events or corporate event	0001104659-23-056863.pdf 0001104659-23-056863.rtf 0001104659-23-056863.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 1, 2023	8-K	Report of unscheduled material events or corporate event	0001104659-23-053509.pdf 0001104659-23-053509.rtf 0001104659-23-053509.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Apr 28, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	0001104659-23-052923.pdf 0001104659-23-052923.rtf 0001104659-23-052923.xls View HTML
Apr 28, 2023	ARS	An annual report to security holders	0001104659-23-052941.pdf 0001104659-23-052941.rtf View HTML
Mar 22, 2023	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001410578-23-000324.pdf 0001410578-23-000324.rtf 0001410578-23-000324.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Mar 22, 2023	8-K	Report of unscheduled material events or corporate event	0001104659-23-035380.pdf 0001104659-23-035380.rtf 0001104659-23-035380.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.